Smoothie Diet

ADHD and autism supplement ads banned as watchdog rules they aim to ‘treat human disease’ – Liam O’Dell

The Advertising Standards Authority (ASA) has banned ads from three companies selling supplements for attention deficit hyperactivity disorder (ADHD) and autism, after it concluded the material featured unauthorised claims they could treat “human disease”.

The use of the term “disease” is despite health bodies and charities – including the NHS and Mind – instead referring to the two labels as “conditions”.

The three paid Facebook ads, which were spotted on the social network in January, March and April, were investigated by the ASA which questioned their compliance with the advertising code set by the Committee of Advertising Practice (CAP).

Ikaria Juice

The companies behind the adverts were Drop Supplements, Spectrum Awakening and Aspire Nutrition.

Drop Supplements’ advert featured text which claimed a bottle of their product ‘Happy Mind’ was “designed to make you feel better” and was “for people with stress, anxiety, brain fog, ADHD”.

It also described the product as a “new secret adaptogen against stress”, adding: “Prepare yourself to unleash your true potential and banish your mental barriers”.

Drop Supplements told the ASA that ads for their ‘Happy Mind’ product “made no direct or implied statements about curing, treating or preventing ailments or diseases” and that claims such as “banish your mental barriers” were part of “a broader lifestyle message that promoted positive thinking and mental resilience” so “no direct or implied health claims had been made”.

The ruling continues: “In addition they explained that the ‘Terms of Service’ on their website had a section called ‘Supplement Disclaimer and Advertising Clarification’ which listed the full terms and conditions. One of the conditions stated their supplements were ‘not intended to cure or prevent any diseases’.”

Spectrum Awakening’s advert promoted a product called ‘Power and Focus’ as “natural nutritional supplements for autism and ADHD”, with a before and after video showing a young boy speaking but forming no words, and then speaking full sentences and responding to questions “a week later”.

Spectrum Awakening, which did not respond to the ASA’s enquiries, has been contacted for comment.

The ad from Aspire Nutrition, meanwhile, branded their product a “the secret weapon parents of ASD [autism spectrum disorder] kids swear by”, and featured a testimonial from a parent – known only as ‘Tara K’ – who claimed she saw meltdowns in her five-year-old autistic son decrease “by 80%” in the first week of taking the supplement.

Meltdowns are described by the National Autistic Society (NAS) as “an intense response to an overwhelming situation”, with the charity advising people to identify causes and minimise triggers to try and reduce their frequency.

Aspire Nutrition told the ASA the marketing material was a “retargeting ad” for customers who had visited its website, and that they “currently did not advertise directly to UK residents”.

“Since being informed of the complaint they had stopped ads being sent to UK residents who visited their website and withdrawn the ad entirely for all audiences,” the ruling reads.

All three were found in breach of rule 15.6.2 of the CAP code, a clause which prohibits “claims that state or imply a food prevents, treats or cures human disease”.

“Reduction-of disease-risk claims are acceptable if authorised on the applicable register,” it adds.

ADHD or autism are not curable, with the NAS writing that there is “no proper scientific evidence of any kind that any products or therapies ‘cure’ autism”.

The companies were also told to ensure future advertising “did not make claims that food” could “prevent, treat or cure human disease”, with the words “human disease” replaced with “human conditions” in the case of The Drop Supplements and coming with the clarification that the conditions “for the purposes of the Code fall within the definition of human disease”.

When asked why it was referring to two neurological conditions – ADHD and autism – as “diseases”, an ASA spokesperson told Liam O’Dell in a statement: “In this case, the CAP Code reflects the current legislation which relates to the types of claims that can be made about foods and food supplements.

“Claims that attribute the property of preventing, treating or curing a human disease can’t be made.

“A number of conditions – including ADHD and autism – fall under the umbrella label of ‘disease’. As such, the Code has to reflect the current legal language.

“However, we recognise that these conditions are not classed as diseases by medical professionals, and that they are not ‘curable’.”

The rule under the CAP Code is echoed EU regulations – namely Article 7 of one known as 1169/2011 – which were brought under UK law as part of the EU (Withdrawal) Act of 2018.

While the regulation does contain the same text on claims relating to human disease, Liam O’Dell has been unable to find any information in legislation which names conditions considered ‘human diseases’ – including ADHD or autism.


Update – 04/07/24 – 15:09: The ASA has since confirmed its reference to autism and ADHD as a “human disease” in these rulings is based on its own “interpretation of the legal language”.

A spokesperson for the regulator also pointed this website towards government guidance on nutrition and health claims in relation to EU regulations, with clause 4.6 stating: “Claims that state, suggest or imply that a food has the property of preventing, treating or curing a human disease will continue to be prohibited by the Food Labelling Regulations 1996 (as amended).”

The ASA also said “when a product is being presented to consumers as a food or food supplement, we follow the law as defined by the MHRA [Medicines and Healthcare products Regulatory Agency]”.

In MHRA guidance from 2020, the agency cites regulations which states “disease” as a term “includes any injury, ailment or adverse condition, whether of body or mind”.

It adds that in relation to “borderline products” – where products sit on the regulatory ‘borderline’ between medicinal products and other items such as food supplements or cosmetic products – it considers a number of examples to be “medicinal claims”.

Those given by the MHRA include “references to all medical conditions major to minor”; “references to condition of the mind such as […] attention deficit/hyperactivity disorder”; and “symptoms of disease such as pain, inflammation etc.”


Images: Pixabay.




Source link

Ikaria Juice

Written by : Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.

Share this article:

Leave A Comment